COMPOSITIONS OF CHOLINESTERASE INHIBITORS
    1.
    发明申请
    COMPOSITIONS OF CHOLINESTERASE INHIBITORS 审中-公开
    胆碱酯酶抑制剂的组成

    公开(公告)号:US20100256229A1

    公开(公告)日:2010-10-07

    申请号:US12753567

    申请日:2010-04-02

    CPC分类号: C07C271/44 C07C57/15

    摘要: The present invention is directed to compositions, methods of use, and processes for the synthesis related to 3-((S)-1-(dimethylamino)ethyl)phenyl methyl-((R)-1-phenylpropan-2 yl)carbamate, and its pharmaceutically acceptable salt forms, including the hydrogen fumarate salt. The present invention also relates to a novel form polymorph of 3-((S)-1-(dimethylamino)ethyl)phenylmethyl-((R)-1-phenylpropan-2 yl)carbamate, characterized by a unique X-ray diffraction pattern and Differential Scanning Calorimetry profile, as well a unique crystalline structure.

    摘要翻译: 本发明涉及与3 - ((S)-1-(二甲基氨基)乙基)苯基甲基 - ((R)-1-苯基丙烷-2-基)氨基甲酸酯相关的组合物,使用方法和合成方法, 及其药学上可接受的盐形式,包括富马酸氢盐。 本发明还涉及3 - ((S)-1-(二甲基氨基)乙基)苯基甲基 - ((R)-1-苯基丙烷-2-基)氨基甲酸酯的新型多晶型物,其特征在于独特的X射线衍射图 和差示扫描量热法,以及独特的晶体结构。